Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.

Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT Jr, Lakshman P, Uluwattage W, Hay P, Pereira T, Amarasena N, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR, Whelton PK, GMRx2 Investigators

Open source

DOI: 10.1016/s0140-6736(24)01744-6
Published: 2024 Oct 19
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-24-01744-6,
  title = {Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.},
  author = {Rodgers A and Salam A and Schutte AE and Cushman WC and de Silva HA and Di Tanna GL and Grobbee DE and Narkiewicz K and Ojji DB and Poulter NR and Schlaich MP and Oparil S and Spiering W and Williams B and Wright JT Jr and Lakshman P and Uluwattage W and Hay P and Pereira T and Amarasena N and Ranasinghe G and Gianacas C and Shanthakumar M and Liu X and Wang N and Gnanenthiran SR and Whelton PK and GMRx2 Investigators},
  year = {2024},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(24)01744-6},
  url = {https://doi.org/10.1016/s0140-6736(24)01744-6}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.
AU  - Rodgers A
AU  - Salam A
AU  - Schutte AE
AU  - Cushman WC
AU  - de Silva HA
AU  - Di Tanna GL
AU  - Grobbee DE
AU  - Narkiewicz K
AU  - Ojji DB
AU  - Poulter NR
AU  - Schlaich MP
AU  - Oparil S
AU  - Spiering W
AU  - Williams B
AU  - Wright JT Jr
AU  - Lakshman P
AU  - Uluwattage W
AU  - Hay P
AU  - Pereira T
AU  - Amarasena N
AU  - Ranasinghe G
AU  - Gianacas C
AU  - Shanthakumar M
AU  - Liu X
AU  - Wang N
AU  - Gnanenthiran SR
AU  - Whelton PK
AU  - GMRx2 Investigators
PY  - 2024
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(24)01744-6
UR  - https://doi.org/10.1016/s0140-6736(24)01744-6
ER  -

APA

A, R., A, S., AE, S., WC, C., HA, D. S., GL, D. T., DE, G., K, N., DB, O., NR, P., MP, S., S, O., W, S., B, W., Jr, W. J., P, L., W, U., P, H., T, P., N, A., G, R., C, G., M, S., X, L., N, W., SR, G., PK, W., & Investigators, G. (2024). Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)01744-6

Source records

pubmed · retrieved 2026-09-26T08:35:58.678Z